Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 267

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 267
---
 (“NorthView”),
where a subsidiary of NorthView will merge with the Company, with the Company surviving the Merger as a wholly owned subsidiary of NorthView.

On February 11, 2025, the parties
to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement (the “Amendment”) pursuant to which the parties
agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received by Profusa
prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment (i) revised
the definition of “Milestone Event III” such that the parties extended the period for Profusa to consummate the APAC Joint
Venture (as defined in the Merger Agreement) and receive the related funding from December 31, 2024 until December 31, 2025, and (ii)
revised the definition of “Milestone Event IV” to change the earnout revenue target from $99,702,000 for the fiscal year ended
December 31, 2025 to an earnout revenue target of $11,864,000 for the fiscal year ended December 31, 2026.

In relation to Milestone Event
III: On August 8, 2023, a new wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (“APAC”), was created and incorporated
by the Company under the laws of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $1,000 for 1,000 Ordinary
Shares. As a result, at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created
with the expectation of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee
Oxygen products, currently under development by the Company, together with a third party. No business or activities will have been conducted
by the entity from the date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement
between the Company and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (“Tasly”)
which is a related party of the Company. In connection with and on or around the same date as the closing of the proposed Merger between
the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders Agreement (the “